ResearcherUniversity of Colorado AnschutzActive in the last 2 years
Adrienne Molnár
Matched on ORCID iD 0000-0002-3088-915X; OpenAlex author ID A5016560330. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 29
2023: 1 paper · 2024: none · 2025: none · 2026: 2 papers
Papers 3
- Neoadjuvant multiagent chemotherapy or upfront surgery for primary resectable pancreatic cancer - A retrospective intention-to-treat analysis. Co-author DOI 10.1016/j.hpb.2026.04.451↗
- Tangential Versus Segmental Portomesenteric Venous Resection During Pancreatoduodenectomy for Pancreatic Cancer: An International Multicenter Cohort Study on S… First author DOI 10.1097/sla.0000000000006638↗
- Portomesenteric venous contact ≤180° and overall survival in resectable head and body pancreatic adenocarcinoma treated with upfront surgery. Co-author DOI 10.1016/j.ejso.2023.107097↗
Closest collaborators
The 25 strongest of 29 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Oskar Franklin · 3 shared papers, 2023–2026 · strength 0.66
- Paper Neoadjuvant multiagent chemotherapy or upfront surgery for primary resectable pancreatic cancer - A retrospective inten… DOI 10.1016/j.hpb.2026.04.451↗
- Paper Portomesenteric venous contact ≤180° and overall survival in resectable head and body pancreatic adenocarcinoma treated… DOI 10.1016/j.ejso.2023.107097↗
- Paper Tangential Versus Segmental Portomesenteric Venous Resection During Pancreatoduodenectomy for Pancreatic Cancer: An Int… DOI 10.1097/sla.0000000000006638↗
- Toshitaka Sugawara · 2 shared papers, 2026 · strength 0.47
- Paper Neoadjuvant multiagent chemotherapy or upfront surgery for primary resectable pancreatic cancer - A retrospective inten… DOI 10.1016/j.hpb.2026.04.451↗
- Paper Tangential Versus Segmental Portomesenteric Venous Resection During Pancreatoduodenectomy for Pancreatic Cancer: An Int… DOI 10.1097/sla.0000000000006638↗
- Thomas F. Stoop · 2 shared papers, 2026 · strength 0.47
- Paper Neoadjuvant multiagent chemotherapy or upfront surgery for primary resectable pancreatic cancer - A retrospective inten… DOI 10.1016/j.hpb.2026.04.451↗
- Paper Tangential Versus Segmental Portomesenteric Venous Resection During Pancreatoduodenectomy for Pancreatic Cancer: An Int… DOI 10.1097/sla.0000000000006638↗
- Marco Del Chiaro · 2 shared papers, 2026 · strength 0.47
- Paper Neoadjuvant multiagent chemotherapy or upfront surgery for primary resectable pancreatic cancer - A retrospective inten… DOI 10.1016/j.hpb.2026.04.451↗
- Paper Tangential Versus Segmental Portomesenteric Venous Resection During Pancreatoduodenectomy for Pancreatic Cancer: An Int… DOI 10.1097/sla.0000000000006638↗
- Richard David Schulick · 2 shared papers, 2026 · strength 0.47
- Paper Neoadjuvant multiagent chemotherapy or upfront surgery for primary resectable pancreatic cancer - A retrospective inten… DOI 10.1016/j.hpb.2026.04.451↗
- Paper Tangential Versus Segmental Portomesenteric Venous Resection During Pancreatoduodenectomy for Pancreatic Cancer: An Int… DOI 10.1097/sla.0000000000006638↗
- Asif Halimi · 2 shared papers, 2023–2026 · strength 0.39
- Paper Portomesenteric venous contact ≤180° and overall survival in resectable head and body pancreatic adenocarcinoma treated… DOI 10.1016/j.ejso.2023.107097↗
- Paper Tangential Versus Segmental Portomesenteric Venous Resection During Pancreatoduodenectomy for Pancreatic Cancer: An Int… DOI 10.1097/sla.0000000000006638↗
- Wells A. Messersmith · 1 shared paper, 2026 · strength 0.28
- Haytham Bayadsi · 1 shared paper, 2023 · strength 0.19
- Jacobien C.M. Scheepens · 1 shared paper, 2026 · strength 0.19
- Bodil Andersson · 1 shared paper, 2026 · strength 0.19
- Yosuke Inoue · 1 shared paper, 2026 · strength 0.19
- Freek D. Daams · 1 shared paper, 2026 · strength 0.19
- Ingmar Florin Rompen · 1 shared paper, 2026 · strength 0.19
- Izaak Quintus Molenaar · 1 shared paper, 2026 · strength 0.19
- Leonard W. F. Seelen · 1 shared paper, 2026 · strength 0.19
- Atsushi Oba · 1 shared paper, 2026 · strength 0.19
- Ernesto Sparrelid · 1 shared paper, 2026 · strength 0.19
- Daisuke Ban · 1 shared paper, 2026 · strength 0.19
- Bas Groot Koerkamp · 1 shared paper, 2026 · strength 0.19
- Poya Ghorbani · 1 shared paper, 2026 · strength 0.19
- Joseph R. Habib · 1 shared paper, 2026 · strength 0.19
- Tatsunori Miyata · 1 shared paper, 2026 · strength 0.19
- Roeland F. de Wilde · 1 shared paper, 2026 · strength 0.19
- Hjalmar C. van Santvoort · 1 shared paper, 2026 · strength 0.19
- Paulina Bereza‐Carlson · 1 shared paper, 2026 · strength 0.19
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.